NeuroMetrix to Present at Canaccord Genuity Medical Technology and Diagnostics Forum

WALTHAM, Mass.--()--NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Canaccord Genuity Medical Technology and Diagnostics Forum at the Westin Grand Central, New York, NY on November 19, 2015. Dr. Gozani intends to provide an update on the Company’s business activities including the Quell® Wearable Pain Relief device.

NeuroMetrix's presentation is scheduled for Thursday, November 19, 2015 at 4:30 pm (Eastern Time). A live audio webcast will be available on the investor relations section of the corporate website - http://www.NeuroMetrix.com/. This webcast will be archived after the live event.

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

$Cashtags

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com